
Prof Manuel Salto Tellez
QUB
Professor Manuel Salto-Tellez (MD-LMS, FRCPath, FRCPI) is the Chair of Molecular Pathology at Queen’s University
By January 2019, Prof Salto-Tellez was
He studied Medicine in Spain (Oviedo), Germany (Aachen) and The Netherlands (Leiden). He specialized in Histopathology in the UK (Edinburgh and London) and in Molecular Pathology in
Prof Salto-Tellez serves in committees associated with CRUK, NICE
Abstract
Histopathology became an established, global and accepted clinical discipline in the first half of the 20th Century. Since then 3 main developments have reshaped the way we practice it.
Immunohistochemistry (IHC) [1] provided important information in both diagnostic and discovery, helping the delivery of a more accurate and sophisticated taxonomy of diseases (diagnostic value), and also the performance of key tests with a genetic, prognostic and predictive value [2]. The second revolution (“the molecular diagnostic revolution”) was different and, in many occasions, this analysis has been performed outside the routine pathological strategies, making pathologists facilitators rather
In our opinion, Digital Pathology (DP) and Artificial Intelligence (AI) represents an incipient “third revolution” that is strongly knocking at the door of pathology. From a practical point of view, DP/AI have the potential to make the complex and fragmented pathway of routine pathological tissue interrogation a more seamless
This lecture will discuss in detail our contributions to the application of DP in
References
1. Soilleux E and Gatter KC. The Antibody Revolution: How ‘Immuno’ Changed Pathology. Chapter 15 in Understanding Disease: A Centenary Celebration of the Pathological Society, 2006, Hall P and Wright NA editors, John Wiley & Sons, Incorporated, ISBN-10 0470032200 & ISBN-13 9780470032206
2. McCourt CM, Boyle D, James J, Salto-Tellez M. Immunohistochemistry in the era of
3. Morphomolecular pathology: setting the framework for a new generation of pathologists. Jones JL, Oien KA, Lee JL, Salto-Tellez M. Br J Cancer. 2017 Nov 21;117(11):1581-1582.
4. Time for change: a new training programme for morpho-molecular pathologists? Moore DA, Young CA, Morris HT, Oien KA, Lee JL, Jones JL, Salto-Tellez M. J Clin Pathol. 2018 Apr;71(4):285-290.
5. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer. Bankhead P, Fernández JA, McArt DG, Boyle DP, Li G, Loughrey MB, Irwin
IACR Membership
We have a number of membership categories available. Find out which membership suits you.
IACR Virtual Conference 2021
Highlighting the spectrum of cancer science, medicine and research across the island of Ireland.
IACR Public Engagement
Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?
Latest News
PhD in Tumour Immunology
A fully funded 4-year PhD studentship (€18,000 per annum stipend) is available in the research group of Dr. Aideen Ryan.
Education Grant 2020
The Irish Association for Cancer Research supported five Educational Grants in 2020. These were made available to postgraduate PhD researchers who had been affected by the Covid-19 pandemic.

Irish Association
for Cancer Research
9A Coolkill, Sandyford
Dublin 18, Ireland
D18 C1W3
info@iacr.ie
+353 (0)295 8859
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.
Registered Charity Number (RCN): 20030117.
©Design by LetterEleven